• Explore /
  • Poster
  • / Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT).

Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT).

Abstract Poster

Authors

null

Max Topp

Medizinische Klinik und Poliklinik II, Würzburg, Bayern, Germany

Max Topp , Anthony Selwyn Stein , Gerhard Zugmaier , Hervé Dombret , Monika Brueggemann , Massimiliano Bonifacio , Xiaoyu Dong , Hagop M. Kantarjian , Ralf C. Bargou , Nicola Gökbuget

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT01466179, NCT01207388

Citation

J Clin Oncol 36, 2018 (suppl; abstr 7044)

DOI

10.1200/JCO.2018.36.15_suppl.7044

Abstract #

7044

Poster Bd #

104

Abstract Disclosures

Similar Posters

First Author: Marcos J.G. De Lima

First Author: Natia Esiashvili

First Author: Olalekan O. Oluwole

First Author: Gun-Dong Lee